NOVAPTECH
Business purpose.
Le développement biotechnologique et la commercialisation d'aptamères. Toutes activités de services de développement d'aptamères à façon. Le conseil expertise aptamères
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Research and experimental development on biotechnology (72.11Z)
- Sector
- Scientific research and development
- Headcount
- 10 to 19 employees
- Created
- 2 Jun 2016
- Share capital
- 350,000.00 EUR
- Registered with the trade register
- 2 Jun 2016
- Financial year end
- 31/12
- Establishments
- 3
Directors
- JEAN-JACQUES TOULME 79 years old, 04/1947 Directeur general
- MARINE LAVILLE 50 years old, 01/1976 President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- TOULMESONS via JEAN-JACQUES TOULME
Other companies at the same address
One other company head office is registered at this address.
Establishments
-
82069034500021 33000 BORDEAUX
-
82069034500013 33600 PESSAC
Financial strength
Financial score
96 / 100 A
Confidence: low · computed on the financial year ended 31 Dec 2024
- Equity to assets (88.1 %)
- 28.6 out of 30
- EBITDA margin
- data missing, component not taken into account
- Liquidity (1,395.3 %)
- 20.0 out of 20
- Debt (8.3 %)
- 13.6 out of 15
- Revenue trend
- data missing, component not taken into account
formula fin-1.0
Legal score
100 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (10.5 years)
- 20.0 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Dec 2024 | 0 € | first year on record | 0 € | 24,546 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale de l'industrie pharmaceutique du 6 avril 1956. Etendue par arrêté du 15 novembre 1956 JORF 14 décembre 1956.
IDCC 0176 · repealed · 1 establishment · declared in August 2026
Legal notices
-
Filing of accounts 25 Jun 2026
- Court :
- Greffe du Tribunal de Commerce de bordeaux
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2025
BODACC C n 20260119, annonce n 4056 · Proof of publication (PDF)
-
Filing of accounts 11 Jul 2025
- Court :
- Greffe du Tribunal de Commerce de bordeaux
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2024
BODACC C n 20250132, annonce n 2293 · Proof of publication (PDF)
-
Filing of accounts 5 Jul 2024
- Court :
- Greffe du Tribunal de Commerce de bordeaux
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2023
BODACC C n 20240129, annonce n 2758 · Proof of publication (PDF)
-
Amendment 10 Jan 2024
- Court :
- Greffe du Tribunal de Commerce de Bordeaux
- Amendment :
- transfert du siège social.
BODACC B n 20240006, annonce n 579 · Proof of publication (PDF)
-
Filing of accounts 20 Jul 2023
- Court :
- Greffe du Tribunal de Commerce de bordeaux
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2022
BODACC C n 20230138, annonce n 1481 · Proof of publication (PDF)
-
Filing of accounts 5 Jul 2022
- Court :
- Greffe du Tribunal de Commerce de bordeaux
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2021
BODACC C n 20220129, annonce n 5314 · Proof of publication (PDF)
-
Filing of accounts 2 Jul 2021
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE BORDEAUX
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2020
BODACC C n 20210128, annonce n 3047 · Proof of publication (PDF)
-
Filing of accounts 9 Aug 2020
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE BORDEAUX
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2019
BODACC C n 20200153, annonce n 5367 · Proof of publication (PDF)
-
Filing of accounts 31 Jul 2019
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE BORDEAUX
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2018
BODACC C n 20190146, annonce n 1574 · Proof of publication (PDF)
Filings and annual accounts as PDF →
Change history
- Appointed: Directeur general 9 Oct 2026
- Appointed: President de SAS 9 Oct 2026
- Registered office: 2 Avenue Favard 33170 Gradignan 2 Oct 2026
Frequently asked questions about NOVAPTECH
- What is the SIREN number of NOVAPTECH?
- The SIREN number of NOVAPTECH is 820690345. Its intra-community VAT number is FR72820690345.
- Where is the head office of NOVAPTECH?
- Head office address: 2 AVENUE FAVARD, 33170 GRADIGNAN.
- When was NOVAPTECH founded?
- NOVAPTECH was founded on 2 Jun 2016.
- What does NOVAPTECH do?
- Its declared main activity is: Research and experimental development on biotechnology (NAF code 72.11Z).
- Who runs NOVAPTECH?
- The officers listed in the register are JEAN-JACQUES TOULME (Directeur general), MARINE LAVILLE (President de SAS).
- What is the revenue of NOVAPTECH?
- The latest published revenue is 0 €, for the 2024 financial year.
- How many employees does NOVAPTECH have?
- The declared headcount is 10 to 19 employees. Insee data for 2024.
- Is NOVAPTECH subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.